logo-loader
AIM:TRX

Tissue Regenix Group PLC

Receive alerts
Market:
AIM
Market Cap:
£23.21 m
Price
0.33 GBX
Change
-4.35%
52 weeks high
4.60
52 weeks low
0.28

In brief

TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.

Deep dive We explore the investor case for growth companies

Snapshot

  • Products spanning wound care, orthopaedics and cardiac application
  • Focused on boosting sales after capacity boost
  • Operations split between the UK and US